U.S. Files False Claims Act Complaint Over Medicare Genetic Test Billing
U.S. government files False Claims Act complaint against medical billing company for submitting false Medicare claims related to unnecessary genetic tests.
DOJ Sues SelectQuote Over Medicare Advantage Kickbacks, Stock Drops 19%
The DOJ sued SelectQuote and major insurers over Medicare Advantage plan kickbacks, leading to a 19% stock drop. This case highlights key compliance risks in broker compensation and Medicare Advantage enrollment.
Genetic Testing Fraud Settlement: $6M Paid to Resolve Medicare False Claims
Genexe, LLC and others pay $6 million to resolve allegations of Medicare fraud involving medically unnecessary genetic tests and kickbacks. Enforcement in healthcare compliance continues.
Court Allows Whistleblower FCA Claims Against UnitedHealthcare Over Medicare Part C Billing
Federal court permits whistleblower FCA claims alleging improper Medicare Part C billing by UnitedHealthcare of Georgia, highlighting compliance scrutiny in Medicare Advantage billing.
Court Allows FCA Whistleblower Case Against UnitedHealthcare Over Medicare Advantage Billing
Federal court permits whistleblower's False Claims Act allegations against UnitedHealthcare for improper Medicare Advantage billing to move forward, highlighting legal risks in healthcare billing compliance.
Vault Medical Services Settles $8M False Claims Act Allegations for COVID-19 Billing
Vault Medical Services agreed to pay $8 million to resolve False Claims Act allegations for improper COVID-19 billing under the federal Uninsured Program, highlighting compliance risks in federally funded healthcare programs.
Medicare Genetic Testing Fraud Case Settled for $6M Over False Claims
Genexe and Immerge settle $6M case resolving false Medicare claims for unnecessary genetic tests involving kickbacks. Settlement addresses healthcare fraud and whistleblower suits under the False Claims Act.
DOJ Reports FCA Settlements Exceeded $2.9 Billion in FY 2024
The DOJ has reported that settlements and judgments for the False Claims Act exceeded $2.9 billion in FY 2024, primarily driven by healthcare fraud.
DOJ Reports $2.9 Billion in FCA Recoveries for FY 2024
The DOJ announced record recoveries under the False Claims Act for FY 2024, totaling over $2.9 billion, driven by significant qui tam filings.